Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “APS”

261 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 261 results

Post-approval studies (Phase 4)Looking for participantsNCT05629494
What this trial is testing

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

Who this might be right for
Prostate CancerProstate InflammationPSA
Albany Medical College 198
Not applicableUnknownNCT06677775
What this trial is testing

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02297412
What this trial is testing

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Who this might be right for
Acute PainBreast CarcinomaPeripheral Neuropathy
Academic and Community Cancer Research United 47
Testing effectiveness (Phase 2)Study completedNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Large-scale testing (Phase 3)Ended earlyNCT03535675
What this trial is testing

Muscadine Plus (MPX) In Men With Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59
Testing effectiveness (Phase 2)Study completedNCT02047253
What this trial is testing

Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Alabama at Birmingham 28
Not applicableUnknownNCT04026763
What this trial is testing

MR/TRUS Fusion Guided Prostate Biopsy

Who this might be right for
Prostate DiseaseElevated Prostate Specific AntigenFamily History of Prostate Cancer+1 more
Icahn School of Medicine at Mount Sinai 520
Post-approval studies (Phase 4)Study completedNCT01296672
What this trial is testing

3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer

Who this might be right for
Prostate Cancer
The University of Texas Health Science Center at San Antonio 383
Large-scale testing (Phase 3)Study completedNCT02680041
What this trial is testing

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 221
Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Not applicableLooking for participantsNCT06862856
What this trial is testing

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Specific Antigen
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT01561482
What this trial is testing

Study of Metformin With Simvastatin for Men With Prostate Carcinoma

Who this might be right for
Prostate Carcinoma
Nicholas Mitsiades
Not applicableUnknownNCT06575140
What this trial is testing

Associative Peripheral Stimulation for Reduction of Motor Impairment During Acute Period of Stroke Recovery

Who this might be right for
StrokeStroke, AcuteStroke, Ischemic+6 more
Ahmed A. Rahim 20
Testing effectiveness (Phase 2)Study completedNCT00286806
What this trial is testing

Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Ascenta Therapeutics 27
Large-scale testing (Phase 3)UnknownNCT02338297
What this trial is testing

Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC

Who this might be right for
Carcinoma, Hepatocellular
Nanjing Medical University 236
Large-scale testing (Phase 3)Study completedNCT00136487
What this trial is testing

Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 85
Not applicableStudy completedNCT02138890
What this trial is testing

APSS-33-00: A Multicenter, Pilot Study of Autologous Protein Solution (APS) in Knee Osteoarthritis (OA)

Who this might be right for
Osteoarthritis, Knee
Zimmer Biomet 46
Not applicableActive Not RecruitingNCT05228197
What this trial is testing

Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.

Who this might be right for
Prostatic Neoplasms
Imperial College London 750
Testing effectiveness (Phase 2)UnknownNCT03579654
What this trial is testing

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

Who this might be right for
Prostate Cancer
OncBioMune Pharmaceuticals 120
Large-scale testing (Phase 3)Ended earlyNCT00840294
What this trial is testing

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

Who this might be right for
Elevated Prostate Specific Antigen
University of Chicago 85
Next Page